BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pennisi M, Bertino G, Gagliano C, Malaguarnera M, Bella R, Borzì AM, Madeddu R, Drago F, Malaguarnera G. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance. Nutrients 2017;9:E897. [PMID: 28820468 DOI: 10.3390/nu9080897] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Lin J, Li X, Chen B, Wei G, Chen D. E-Configuration Improves Antioxidant and Cytoprotective Capacities of Resveratrols. Molecules 2018;23:E1790. [PMID: 30036971 DOI: 10.3390/molecules23071790] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vicari E, Salemi M, Sidoti G, Malaguarnera M, Castiglione R. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome. Nutrients. 2017;9. [PMID: 29099760 DOI: 10.3390/nu9111208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
3 Plotogea OM, Ilie M, Bungau S, Chiotoroiu AL, Stanescu AMA, Diaconu CC. Comprehensive Overview of Sleep Disorders in Patients with Chronic Liver Disease. Brain Sci 2021;11:142. [PMID: 33499194 DOI: 10.3390/brainsci11020142] [Reference Citation Analysis]
4 Kim YK, Song J. Therapeutic Applications of Resveratrol in Hepatic Encephalopathy through Its Regulation of the Microbiota, Brain Edema, and Inflammation. J Clin Med 2021;10:3819. [PMID: 34501267 DOI: 10.3390/jcm10173819] [Reference Citation Analysis]
5 Hu JH, Chang M, Liu N, Yeh C, Huang T. Risk and Protective Factors Associated with Daytime Sleepiness in Patients Diagnosed with Hepatitis B or Hepatitis C Infection. Hepat Mon 2021;20. [DOI: 10.5812/hepatmon.107606] [Reference Citation Analysis]
6 Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgrad Med J 2021:postgradmedj-2020-139319. [PMID: 33441476 DOI: 10.1136/postgradmedj-2020-139319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. J Thorac Dis 2020;12:S248-60. [PMID: 33214928 DOI: 10.21037/jtd-cus-2020-012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
8 Malaguarnera G, Madeddu R, Catania VE, Bertino G, Morelli L, Perrotta RE, Drago F, Malaguarnera M, Latteri S. Anorectal mucosal melanoma. Oncotarget 2018;9:8785-800. [PMID: 29492238 DOI: 10.18632/oncotarget.23835] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
9 Malaguarnera G, Pennisi M, Bertino G, Motta M, Borzì AM, Vicari E, Bella R, Drago F, Malaguarnera M. Resveratrol in Patients with Minimal Hepatic Encephalopathy. Nutrients 2018;10:E329. [PMID: 29522439 DOI: 10.3390/nu10030329] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
10 Darand M, Farrokhzad A, Ghavami A, Hadi A, Karimi E, Fadel A, Askari G. Effects of resveratrol supplementation on liver enzymes: A systematic review and meta-analysis of randomised controlled trials. Int J Clin Pract 2021;75:e13692. [PMID: 32869460 DOI: 10.1111/ijcp.13692] [Reference Citation Analysis]
11 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases. J Clin Med 2018;8:E16. [PMID: 30583494 DOI: 10.3390/jcm8010016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li X, Feng Y, Wang XX, Truong D, Wu YC. The Critical Role of SIRT1 in Parkinson's Disease: Mechanism and Therapeutic Considerations. Aging Dis 2020;11:1608-22. [PMID: 33269110 DOI: 10.14336/AD.2020.0216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
13 Nishikawa H, Yoh K, Enomoto H, Iwata Y, Nishimura T, Nishiguchi S, Iijima H. Frailty and Sleep Disorder in Chronic Liver Diseases. Life (Basel) 2020;10:E137. [PMID: 32764402 DOI: 10.3390/life10080137] [Reference Citation Analysis]
14 Malaguarnera L. Influence of Resveratrol on the Immune Response. Nutrients 2019;11:E946. [PMID: 31035454 DOI: 10.3390/nu11050946] [Cited by in Crossref: 106] [Cited by in F6Publishing: 98] [Article Influence: 35.3] [Reference Citation Analysis]
15 Peng J. The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties. Front Pharmacol 2018;9:455. [PMID: 29922155 DOI: 10.3389/fphar.2018.00455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]